The Ypsomed Group (SIX:YPSN), a leading medical technology firm, today announced in its semi-annual report that the company will collaborate with Thin Film Electronics ASA to incorporate NFC OpenSense technology into its line of YpsoMate autoinjection devices.
This information is subject of the disclosure requirements acc. to §5-12 vphl (Norwegian Securities Trading Act)